Improved cerebrospinal fluid-based discrimination between Alzheimer’s disease patients and controls after correction for ventricular volumes

Manuscript Number: 

16-0668R2

Author(s): 
Andrea Arighi, Inês Baldeiras, Kaj Blennow, Marco Bozzali, Miguel Castelo-Branco, Enrica Cavedo, Jurgen A.H.R. Claassen, Derya Durusu Emek-Savaş, Erden Eren, Paolo Eusebi, Lucia Farotti, Chiara Fenoglio, Juan Fortea Ormaechea, Yvonne Freund-Levi, Giovanni B. Frisoni, Daniela Galimberti, Sermin Genc, Juan D. Gispert, Viviana Greco, Harald Hampel, Sanna-Kaisa Herukka, H. Bea Kuiperij, Yawu Liu, Albert Lladó, Alberto Lleó, Olga Meulenbroek, José-Luis Molinuevo, Flavio Nobili, Kader K. Oguz, Lucilla Parnetti, João Pereira, Agnese Picco, Maria Pikkarainen, Catarina Resende de Oliveira, Esen Saka, Nicola Salvadori, Isabel Santana, Elio Scarpini, Philip Scheltens, Hilkka Soininen, Raquel Sánchez-Valle, Roberto Tarducci, Charlotte E. Teunissen, Magda Tsolaki, Andrea Urbani, Marcel M. Verbeek, Eduard Vilaplana Martinez, Pieter Jelle Visser, Asa K. Wallin, Görsev G. Yener, Linda J.C. van Waalwijk van Doorn

Disclosures

Andrea Arighi

  • Nothing to Disclose

Inês Baldeiras

  • Nothing to Disclose

Kaj Blennow

  • Consulting Fees:
    Fujirebio europe, Roche Diagnostics, IBL International

Marco Bozzali

  • Nothing to Disclose

Miguel Castelo-Branco

  • Nothing to Disclose

Enrica Cavedo

  • Nothing to Disclose

Jurgen A.H.R. Claassen

  • Nothing to Disclose

Derya Durusu Emek-Savaş

  • Nothing to Disclose

Erden Eren

  • Nothing to Disclose

Paolo Eusebi

  • Nothing to Disclose

Lucia Farotti

  • Nothing to Disclose

Chiara Fenoglio

  • Nothing to Disclose

Juan Fortea Ormaechea

  • Nothing to Disclose

Yvonne Freund-Levi

  • Nothing to Disclose

Giovanni B. Frisoni

  • Consulting Fees:
    (Advisory Board): Astra Zeneca, Elan, GE, Lilly, Lundbeck, Pfizer, Taurx.
    Grants
    • Agency: 
      Alzheimer Forum
    • Agency: 
      ASSM
    • Agency: 
      Avid/Lilly
    • Agency: 
      Biogen
    • Agency: 
      GE Int.l
    • Agency: 
      Guerbet
    • Agency: 
      IFRAD Suisse
    • Agency: 
      Ixico
    • Agency: 
      Merz
    • Agency: 
      Nestlé
    • Agency: 
      Novartis
    • Agency: 
      Piramal
    • Agency: 
      Roche
    • Agency: 
      Siemens
    • Agency: 
      Teva pharma
    • Agency: 
      Viforpharma
    • Agency: 
      Alzheimer’s Association

Daniela Galimberti

  • Nothing to Disclose

Sermin Genc

  • Nothing to Disclose

Juan D. Gispert

  • Nothing to Disclose

Viviana Greco

  • Nothing to Disclose

Harald Hampel

  • Consulting Fees:
    Eli Lilly and company, GE Healthcare, Roche Diagnostics, Cytox, Anavex, Axovant, Jung Diagnostics, Oryzon Genomics
    Lecture Fees:
    Biogen, Roche, Cytox, Eli Lilly and company
    Patents/Royalties
    I am co-inventor in the following patents as a scientific expert and have receive no royalties: - In vitro multiparameter determination method for the Diagnosis and early diagnosis of neurodegenerative disorders Patent number: 8916388 - In vitro procedure for diagnosis and early diagnosis of neurodegenerative diseases Patent number: 8298784 - Neurodegenerative Markers for Psychiatric Conditions Publication number: 20120196300 - IN VITRO MULTIPARAMETER DETERMINATION METHOD FOR THE DIAGNOSIS AND EARLY DIAGNOSIS OF NEURODEGENERATIVE DISORDERS Publication number: 20100062463 - IN VITRO METHOD FOR THE DIAGNOSIS AND EARLY DIAGNOSIS OF NEURODEGENERATIVE DISORDERS Publication number: 20100035286 - In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Publication number: 20090263822 - In vitro method for the diagnosis of neurodegenerative diseases Patent number: 7547553 - CSF Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases Publication number: 20080206797 - In Vitro Method For the Diagnosis of Neurodegenerative Diseases Publication number: 20080199966 - Neurodegenerative Markers for Psychiatric Conditions Publication number: 20080131921

Sanna-Kaisa Herukka

  • Nothing to Disclose

H. Bea Kuiperij

  • Nothing to Disclose

Yawu Liu

  • Nothing to Disclose

Albert Lladó

  • Nothing to Disclose

Alberto Lleó

  • Nothing to Disclose

Olga Meulenbroek

  • Nothing to Disclose

José-Luis Molinuevo

  • Nothing to Disclose

Flavio Nobili

  • Lecture Fees:
    Teaching course for reading amyloid PET from Eli Lilly & Co 2015

Kader K. Oguz

  • Nothing to Disclose

Lucilla Parnetti

  • Nothing to Disclose

João Pereira

  • Nothing to Disclose

Agnese Picco

  • Nothing to Disclose

Maria Pikkarainen

  • Nothing to Disclose

Catarina Resende de Oliveira

  • Nothing to Disclose

Esen Saka

  • Nothing to Disclose

Nicola Salvadori

  • Nothing to Disclose

Raquel Sánchez-Valle

  • Nothing to Disclose

Isabel Santana

  • Nothing to Disclose

Elio Scarpini

  • Nothing to Disclose

Philip Scheltens

  • Nothing to Disclose

Hilkka Soininen

  • Consulting Fees:
    ACImmune for consulting.

Roberto Tarducci

  • Nothing to Disclose

Charlotte E. Teunissen

  • Consulting Fees:
    Dr. Teunissen serves on the advisory board of Fujirebio and Roche

Magda Tsolaki

  • Nothing to Disclose

Andrea Urbani

  • Nothing to Disclose

Linda J.C. van Waalwijk van Doorn

  • Nothing to Disclose

Marcel M. Verbeek

  • Nothing to Disclose

Eduard Vilaplana Martinez

  • Nothing to Disclose

Pieter Jelle Visser

  • Nothing to Disclose

Asa K. Wallin

  • Nothing to Disclose

Görsev G. Yener

  • Nothing to Disclose